U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

POLYLACTIDE (0.4 DL/G)

MORE DETAILS

7B01B0FN51

Status:
Other
Class:
POLYMER

POLYLACTIDE, L-

MORE DETAILS

W92NDP347A

Status:
Possibly Marketed Outside US
Source:
NCT00126308: Phase 4 Interventional Terminated HIV-Associated Lipodystrophy
(2005)
Source URL:
https://clinicaltrials.gov/ct2/show/NCT00126308
First approved in 1985
Source:
NDA020263
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e99f47d2-da10-3127-ecb3-e5d942ae6e81
Class:
POLYMER
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966